Factors Associated with Residual Symptoms of COVID-19 Virus at Infection among Health Care Personnel Roi Et Hospital
Keywords:
Coronavirus disease 2019, Long COVID-19, Personnel of Roi Et HospitaAbstract
Background and Objective: The symptoms of post COVID-19 infection often persist for several weeks after infection. The objective of this study was to investigate the factors associated with post symptoms after COVID-19 infection at a among health care personnel Roi Et hospital.
Methods: This study was cross-sectional analytical study. Data were collected from 770 staffs of Roi Et Hospital who were infected with COVID-19 between July 2021 and June 2022. Data were analyzed using descriptive statistics, univariate analysis and multiple logistic regressions. The statistically significant was set at p<0.05.
Results: Of 770 stuffs were infected with COVID-19, most of them (76.36%) were female mean age was 37.13± 9.09 years. Most of the clinical symptoms at the time of infection were coughing 81.28 %, sore throat 80.05%, fever 67.03% and runny nose 61.19%. There were 603 stuffs with residual symptoms after COVID-19 infection. The majority symptoms were fatigue 81.92%, coughing 41.29%, dyspnea 40.80%. Factors associated with long COVID-19 infection were male (Adj. OR= 2.53; 95%CI: 1.95-4.66), age > 50 (Adj. OR=2.78 95% CI: 1.64-5.18) Body Mass Index > 30 kg/m2 (Adj. OR=2.41; 95%CI: 1.46-4.32), underlying disease more than one (Adj. OR=1.89; 95% CI: 1.10-4.80). The clinical factor more than one symptom (Adj. OR= 2.45; 95%CI: 1.11-3.53), cough (Adj. OR=1.26; 95%CI1.17- 2.68), sore throat (Adj. OR=1.63; 95%CI: 1.06-2.51), and dyspnea (Adj. OR=1.58; 95% CI: 1.01-3.08).
Conclusion: This study found that the factors associated with long COVID-19 infection among staffs of Roi Et hospital were male, age > 50 years, overweight class 1 or more, had at least one underlying disease, especially those had at least one clinical symptom and who had cough, sore throat, and dyspnea.
References
COVID-19. In: Wikipedia [Internet]. 2022 [cited Nov 14, 2022]. Available from: https://en.wikipedia.org/w/index.php?title=COVID-19&oldid=1120828330
COVID-19 pandemic -19. In: Wikipedia [Internet]. 2022 [cited Nov 14, 2022]. Available from: https://th.wikipedia.org/w/index.php?title=
COVID Live - Coronavirus Statistics - Worldometer [Internet]. [cited Nov 14, 2022]. Available from: https://www.worldometers.info/coronavirus/
Corona virus disease 2019. In: Wikipedia [Internet]. 2022 [cited Nov 14, 2022]. Available from: https://th.wikipedia.org/w/index.php?title=
Pandemic of COVID-19 in Thailand. In: Wikipedia [Internet]. 2022 [cited Nov 14, 2022]. Availablefrom:https://th.wikipedia.org/w/index.php?title=
CDC. COVID-19 and Your Health [Internet]. Centers for Disease Control and Prevention. 2020 [cited Nov 14, 2022, ]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Coronavirus (COVID-19) symptoms in adults [Internet]. nhs.uk. 2020 [cited Nov 14, 2022]. Available from: https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms/main-symptoms/
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021;114(9):428–42.
Ziauddeen N, Gurdasani D, O’Hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics and impact of Long Covid: Findings from an online survey. PloS One 2022;17(3):e0264331.
Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun 2021;94:138–47.
Hossain MA, Hossain KMA, Saunders K, Uddin Z, Walton LM, Raigangar V, et al. Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors. BMJ Glob Health 2021;6(12):e006838.
Staffolani S, Iencinella V, Cimatti M, Tavio M. Long COVID-19 syndrome as a fourth phase of SARS-CoV-2 infection. Infez Med 2022;30(1):22–9.
Vimercati L, De Maria L, Quarato M, Caputi A, Gesualdo L, Migliore G, et al. Association between Long COVID and Overweight/Obesity. J Clin Med 2021;10(18):4143.
Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PloS One 2021;16(12):e0260568.
Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, et al. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmatic Obs Res 2021;12:93–104.
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis Lond Engl 2021;53(10):737–54.
Daniel, Wayne W. Biostatistics — A Foundations for Analysis in the Health Sciences. Wiley & Sons, New York—Chichester—Brisbane—Toronto—Singapore, 6th ed., 1995: 780S.
Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health 2021;6(9):e005427.
Razai MS, Al-Bedaery R, Anand L, Fitch K, Okechukwu H, Saraki TM, et al. Patients’ experiences of “Long COVID” in the community and recommendations for improving services: A quality improvement survey. J Prim Care Community Health 2021;12:21501327211041850.
Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PloS One 2020;15(12):e0243882.
Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol 2022;94(1):253–62.
Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022 12;13(1):1957.
Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2021;2:CD013665.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Srinagarind Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.